DTI | DENTAL TECHNOLOGIES INC APPOINTS LEE CULP, CDT CHIEF TECHNOLOGY OFFICER

Dublin, California, March 18, 2010—Dental Technologies, Inc. (DTI), one of the largest networks of dental laboratories in North America, today announced the appointment of Lee Culp, CDT to the position of Chief Technology Officer (CTO).

Mr. Culp brings more than 30 years of laboratory and technology experience to DTI. Prior to joining the company, he served as Vice-President of Dental Technologies at D4D Technologies, where he guided the development of a variety of technologies for use in both dental practices and dental laboratories.

“We are very pleased to have Lee join the company,” said Kimberly L. Bradshaw, President and CEO of DTI. “For years Lee has been an advocate for advancing technology in our industry and has been closely involved in its development. He shares our vision of the convergence of technology, quality and aesthetics in the dental laboratory industry and will play an integral role in leveraging this throughout our network.”

Mr. Culp added, “DTI's foundation for excellence in aesthetics, function, and customer service combined with their corporate commitment to digital technology keeps them at the forefront of dentistry and the dental laboratory profession. I am very excited about this opportunity to become part of the DTI team and assist in their continued growth and success.”

JEFFREY ZELLMER NAMED CHIEF FINANCIAL OFFICER OF DTI (DENTAL TECHNOLOGIES, INC.)

Dublin, California, March 24, 2010—Dental Technologies, Inc. (DTI), a network of high-quality, full-service dental laboratories located throughout North America, today announced the appointment of Jeffrey Zellmer to the position of Chief Financial Officer (CFO).

Mr. Zellmer has over 25 years of financial executive experience, including five years as CFO of publicly-traded Silicon Graphics, Inc. Most recently, he was Vice President of Finance for Lam Research Corporation, a publicly-traded technology company.

“We are very excited to have added someone of Jeff’s caliber to our Executive Team,” said Kimberly L. Bradshaw, President and CEO of DTI. “He has a strong history of building high-performing finance teams and has a demonstrated track record of building and maintaining financial and operational controls in high-growth corporate environments. Jeff also brings deep experience in financial planning and analysis.”

As CFO of DTI, Mr. Zellmer will be responsible for building an Accounting, Finance and Information Technology organization at DTI's headquarters in Dublin, California. Additionally, he will lead the transitions of these functions from a shared-services model currently located in another state.

Mr. Zellmer’s appointment follows the recent announcement that Lee Culp, CDT would join the company as Chief Technology Officer. Ms. Bradshaw commented, “Jeff and Lee will be instrumental in strengthening our management team, and they share our commitment to delivering customer satisfaction, driving growth and becoming the industry’s preeminent leader in the world of digital dentistry.”

About DTI

DTI is the only dental laboratory network that provides innovative full practice growth support to dentists who want to excel above the status quo.  The Company is a leader in digital dentistry which includes CAD/CAM restorations. Strategically located throughout North America, DTI’s laboratory network extends beyond a simple dental laboratory support as each laboratory represents an epicenter of innovation and artistry for the benefit of each practice we serve.

HealthpointCapital, LLC announced today the acquisition of DTI | Dental Technologies, Inc.

NEW YORK, New York, VANCOUVER, Canada, and DUBLIN, California, March 12, 2007 /PRNewswire/ -- (“DTI” or “Micro”) by its portfolio company, DTI | Dental Technologies Inc. (“DTI”). DTI is the world’s leading cosmetic dentistry laboratory and maker of industry-leading MACVENEERS™. In the past 42 years, it has developed strong relationships with the nation’s most-prominent cosmetic dentists and is renowned for supplying award-winning, custom-manufactured restorative, reconstructive and cosmetic dental products such as crowns, bridges, veneers, implants, and dentures. Prior to this transaction, DTI had been a portfolio company of Riverside Partners since 2001. Terms of the transaction were not disclosed.

“The dental market represents one of the fastest growing sectors in the medical technology industry,” stated John H. Foster, Chairman of the Board of DTI and Chairman and Managing Director of HealthpointCapital. “The dental laboratory industry is a primary beneficiary of the public’s increasing interest in and willingness to pay for improved dental function and aesthetics. We were particularly attracted to DTI because of its strong brand, the depth of its management team and staff, and the relationships it has built through unparalleled service to cosmetically-oriented dentists.

The combination of MicroDental and DTI will create significant value because of its increased ability to utilize the latest in technology and provide continuing education to its technicians and dentists, while maintaining the service levels our clients expect.”

DTI | Dental Technologies Inc

DTI is the world’s largest and most advanced cosmetic dental laboratory, setting the industry standard for innovation and quality for more than 40 years. DTI works closely with leading manufacturers, cosmetic dentists and professional organizations to help develop new materials, dental procedures and meaningful continuing educational opportunities for dental industry professionals. The company holds numerous patents, and many of the procedures DTI has developed have become industry best practices. DTI employs over 900 people.

Headquartered in Dublin, CA, DTI custom designs and fabricates crowns, bridges, dentures, cosmetic appliances and orthodontic appliances for its customers, dentists serving patients in need of restorative and cosmetic dentistry. DTI was founded in 1997 and has grown into one of the largest dental laboratory companies in the world with over 400 employees and a network of 16 labs in Canada and the United States. Consistency, quality, and communication are the cornerstones of success for each of DTI's labs and enable DTI to deliver “Peace of Mind” to its clientele.

HealthpointCapital, LLC

HealthpointCapital is a values-driven, research-based private equity firm exclusively focused on orthopedic and the broadly based musculoskeletal businesses, the fastest growing segment within the medical device industry. Our cumulative 70 years of experience in healthcare technology, research and private investing enable us to help our clients capitalize on the explosive growth and unique investment opportunities in this sector. HealthpointCapital has approximately $600 million of institutional capital.